These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38795844)

  • 1. A comparison of obstetric and neonatal outcomes in polycystic ovary syndrome and congenital adrenal hyperplasia: a retrospective analysis of a population database.
    Kolokythas A; Badeghiesh A; Baghlaf H; Dahan MH
    F S Sci; 2024 Aug; 5(3):293-300. PubMed ID: 38795844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy, delivery and neonatal outcomes among women with congenital adrenal hyperplasia: a study of a large US database.
    Badeghiesh A; Ismail S; Baghlaf H; Suarthana E; Dahan MH
    Reprod Biomed Online; 2020 Dec; 41(6):1093-1099. PubMed ID: 33008769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts.
    Farland LV; Stern JE; Liu CL; Cabral HJ; Coddington CC; Diop H; Dukhovny D; Hwang S; Missmer SA
    Hum Reprod; 2022 Oct; 37(11):2690-2699. PubMed ID: 36149255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of 9.1 million births.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Aug; 35(8):1914-1921. PubMed ID: 32644124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bariatric surgery on polycystic ovary syndrome patients' obstetric and neonatal outcomes: a population-based study.
    Hochberg A; Bazarah MS; Baghlaf HA; Badeghiesh AM; Dahan MH
    J Assist Reprod Genet; 2024 Jun; 41(6):1687-1697. PubMed ID: 38689082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies.
    Mills G; Badeghiesh A; Suarthana E; Baghlaf H; Dahan MH
    Hum Reprod; 2020 Jul; 35(7):1666-1674. PubMed ID: 32535629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hyperandrogenism on obstetric complications of singleton pregnancy from in vitro fertilization in women with polycystic ovary syndrome].
    Wei DM; Zhang ZZ; Wang Z; Li P; Wang JF; Liu YJ; Zhang JT; Shi YH
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):18-22. PubMed ID: 29374881
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in adverse obstetrical and neonatal outcomes over time in American women with polycystic ovary syndrome: an 11-year study of a population database.
    Roper M; Badeghiesh A; Baghlaf H; Dahan MH
    Arch Gynecol Obstet; 2024 Sep; 310(3):1709-1719. PubMed ID: 39009866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperandrogenism and phenotypes of polycystic ovary syndrome are not associated with differences in obstetric outcomes.
    Mumm H; Jensen DM; Sørensen JA; Andersen LL; Ravn P; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):204-11. PubMed ID: 25417943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome and risk of adverse obstetric outcomes: a retrospective population-based matched cohort study in England.
    Subramanian A; Lee SI; Phillips K; Toulis KA; Kempegowda P; O'Reilly MW; Adderley NJ; Thangaratinam S; Arlt W; Nirantharakumar K
    BMC Med; 2022 Aug; 20(1):298. PubMed ID: 36038914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study.
    Fornes R; Simin J; Nguyen MH; Cruz G; Crisosto N; van der Schaaf M; Engstrand L; Brusselaers N
    Reprod Biol Endocrinol; 2022 Feb; 20(1):30. PubMed ID: 35130922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between obesity in women with polycystic ovary syndrome and adverse obstetric outcomes.
    Peeva M; Badeghiesh A; Baghlaf H; Dahan MH
    Reprod Biomed Online; 2022 Jul; 45(1):159-167. PubMed ID: 35577722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
    Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
    Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of preterm delivery and pre-eclampsia in women with polycystic ovary syndrome and hyperandrogenaemia.
    Naver KV; Grinsted J; Larsen SO; Hedley PL; Jørgensen FS; Christiansen M; Nilas L
    BJOG; 2014 Apr; 121(5):575-81. PubMed ID: 24418062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse obstetric outcomes in women with PCOS and multiple gestations.
    Peeva M; Badeghiesh A; Baghlaf H; Dahan MH
    Reprod Biomed Online; 2023 Feb; 46(2):379-389. PubMed ID: 36503681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of maternal polycystic ovary syndrome and diabetes with preterm birth and offspring birth size: a population-based cohort study.
    Chen X; Gissler M; Lavebratt C
    Hum Reprod; 2022 May; 37(6):1311-1323. PubMed ID: 35348682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy, delivery, and neonatal outcomes among women living with Down syndrome: a matched cohort study, utilizing a population database.
    Alnoman A; Baghlaf HA; Badeghiesh AM; Peeva M; Dahan MH
    Arch Gynecol Obstet; 2024 Jun; 309(6):2681-2687. PubMed ID: 37698605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of hyperandrogenemia on pregnancy complications and outcomes in patients with PCOS: a systematic review and meta-analysis.
    Guo X; Yao Y; Wang T; Wu J; Jiang R
    Hypertens Pregnancy; 2024 Dec; 43(1):2379389. PubMed ID: 39004840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the risk of adverse pregnancy outcomes of Chinese patients with polycystic ovary syndrome with and without antiandrogenic pretreatment.
    Li Y; Ruan X; Wang H; Li X; Cai G; Du J; Wang L; Zhao Y; Mueck AO
    Fertil Steril; 2018 Apr; 109(4):720-727. PubMed ID: 29525688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype.
    de Wilde MA; Lamain-de Ruiter M; Veltman-Verhulst SM; Kwee A; Laven JS; Lambalk CB; Eijkemans MJC; Franx A; Fauser BCJM; Koster MPH
    Fertil Steril; 2017 Aug; 108(2):333-340. PubMed ID: 28778282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.